Atlas Trials

KRDI in Transplant-Eligible MM

Clinical trial NCT04430894 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04430894
Sponsor
Massachusetts General Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2020-07-10
Primary completion
2022-07-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.